The relationship between C-reactive protein and subclinical carotid arteriosclerosis in military pilots;Povezanost nivoa C-reaktivnog proteina i preklinièke karotidne arterioskleroze kod vojnih pilota

Vojnosanitetski Pregled

Volumn 66, Issue 6, 2009, Pages 465-471

  Jovelić, Aleksandra ^a   Raden, Slavica ^b   Hajduković, Zoran ^b   Čanji, Tibor ^a  

^a Klinika za kardiologiju   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Arteriosclerosis; C reactive protein; Carotid artery, common; Military personnel; Ultrasonics

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AIRPLANE PILOT; ARMY; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; REGRESSION ANALYSIS; SMOKING; WAIST CIRCUMFERENCE;

EID: 67650561654     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0906465J     Document Type: Article

References (40)

1. McCrary BF, Van Syoc DL. Permanent flying disqualifications of USAF pilots and navigators (1995-1999). Aviat Space Environ Med 2002; 73(11): 1117-1121
2. Taneja N, Wiegmann DA. Prevalence of cardiovascular abnormalities in pilots involved in fatal general aviation airplane accidents. Aviat Space Environ Med 2002; 73(10): 1025-1030
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105(9): 1135-1143
4. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003; 96(11): 793-807. (Pubitemid 37369294)
5. Koenig W, Löwel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004; 109(11): 1349-1353 (Pubitemid 38387819)
6. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350(14): 1387-1397 (Pubitemid 38419992)
7. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107(3): 391-397
8. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J Hypertens 2003; 21(10): 1787-1803 (Pubitemid 37290094)
9. Kuller LH, Tracy RP. The role of inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2000; 20(4): 901.
10. Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004; 109(5): 647-655 (Pubitemid 38198873)
11. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intimamedia thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20(2): 159-169 (Pubitemid 34913777)
12. Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther 2002; 16(4): 341-351 (Pubitemid 36174170)
13. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999; 19(8): 1986-1991 (Pubitemid 29379933)
14. Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y, et al. Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88(2): 112-117
15. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002 ; 22(10): 1662-1667
16. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007; 99(11): 1598-1602 (Pubitemid 46773027)
17. Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmetz H. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk 2002; 9(2): 97-103. (Pubitemid 34553589)
18. Winbeck K, Kukla C, Poppert H, Klingelhöfer J, Conrad B, Sander D. Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovasc Dis 2002; 13(1): 57-63. (Pubitemid 34124172)
19. Jovelić A. C-reactive protein as a marker of preclinical atherosclerosis in military pilots of Serbia and Montenegro [master thesis]. Belgrade: Military Medical Academy; 2004. (Serbian)
20. Hee Choi S, Chang Kim H, Woo Ahn C, Keun Cho H, Soo Cha B, Chung YS, et al. Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?. Eur J Cardiovasc Prev Rehabil 2005; 12(6): 548-554 (Pubitemid 44972983)
21. Elias-Smale SE, Kardys I, Oudkerk M, Hofman A, Witteman JC. Creactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 2007; 195(2): e195-202. (Pubitemid 350087990)
22. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
23. Fisbach F. Chemistry studies. In: Fischbach F, editor. 6th ed. A manual of laboratory & diagnostic tests. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 6: 467.
24. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107(3): 499-511.
25. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000; 101(1): E16-22.
26. Osswald S, Miles R, Nixon W, Celio P. Review of cardiac events in USAF aviators. Aviat Space Environ Med 1996; 67(11): 1023-1027 (Pubitemid 26372499)
27. Munford RS. Statins and the acute-phase response. N Engl J Med 2001; 344(26): 2016-2018
28. Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999; 145(2): 375-379 (Pubitemid 29359147)
29. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, et al. C-reactive protein, carotid intima-media thickness, and inci dence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 2003; 108(2): 166-170 (Pubitemid 36871298)
30. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007; 116(1): 32-38 (Pubitemid 47016244)
31. Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002; 105(17): 2019-2023 (Pubitemid 34465262)
32. Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation 2004; 109(8): 1010-1015 (Pubitemid 38282854)
33. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci (Lond) 1995; 88(4): 485-489
34. Hulthe J, Wikstrand J, Fagerberg B. Relationship between Creactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Lond) 2001; 100(4): 371-378 (Pubitemid 32324334)
35. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24(1): 29-33.
36. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15(11): 2792-2800 (Pubitemid 41103388)
37. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25(10): 1407-1415 (Pubitemid 32977855)
38. van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, Kiliaan AJ, et al. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2002; 22(5): 838-842 (Pubitemid 34517798)
39. Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004; 109(5): 647-655 (Pubitemid 38198873)
40. Koenig W. C-reactive protein and cardiovascular risk: an update on what is going on in cardiology. Nephrol Dial Transplant 2003; 18(6): 1039-1041 (Pubitemid 36722499)